Loading
Latest filing published 10 Jul 2025 for Akoya Biosciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Niro Ph.D Ramachandran in Akoya Biosciences, Inc. In total, 12 filings cover trades dated from 19 November 2021 to 8 July 2025.
Every open-market trade on record is a purchase: 1 purchase worth €825, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants and 2 option exercises.
The record was last updated on 10 July 2025 with a transaction in Akoya Biosciences, Inc. The most recent open-market purchase was published on 22 November 2021, 1,791 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations